Jiakun Mei

Integrating preoperative multiregion radiomic features with clinical data to predict atrial fibrillation recurrence after radiofrequency ablation

Hui Yan, Xiao-Le Li, Jiakun Mei, Lei Zhou et autres

Objective To develop and validate a prediction framework integrating clinical data, left atrium and pulmonary vein morphology, and radiomic features to identify patients at high risk of atrial fibrillation (AF) recurrence after radiofrequency ablation (RFA). Methods Patients with AF who underwent RFA …

cn (code pays fourni par la source)

A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract Cancer

Jiakun Mei, Xue Han⊗, Kai Zhang, Naijian Ge et autres

BACKGROUND & AIMS: First-line immuno-chemotherapy is standard for advanced biliary tract cancer (BTC), but outcomes vary substantially, necessitating longitudinal monitoring and treatment adaptation. We aimed to develop models that dynamically update survival predictions using evolving clinical data to support real-time prognostic stratification. …

cn (code pays fourni par la source)

Machine Learning–Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma

Jiakun Mei, Kai Zhang, Ying Zhang, Zhen Li et autres

BACKGROUND & AIMS: Immunochemotherapy (IO-chemo) has become standard care for patients with unresectable intrahepatic cholangiocarcinoma (iCCA), but benefit of adding IO varies greatly among individuals. We sought to develop a system to identify patients most likely to benefit from this treatment based …

cn (code pays fourni par la source)

Causal machine learning–guided personalized immunochemotherapy strategies in intrahepatic cholangiocarcinoma (CMICC).

Jiakun Mei, Jian Lu, Kai Zhang, Ying Zhang et autres

1 Background: Immunochemotherapy (IO-chemo) has become the first-line standard care for patients with advanced intrahepatic cholangiocarcinoma (iCCA), but the incremental benefit of adding IO varies greatly among individuals, making it urgent to develop systems for identifying high-benefit populations based on individualized treatment …

cn, us (code pays fourni par la source)

125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulation

Jiakun Mei, Kai Zhang, Zhi‐Cheng Jin, Wei‐Fu Lv et autres

BACKGROUND: Patients with hepatocellular carcinoma (HCC) and Vp4 portal vein tumor thrombosis (PVTT) have a poor prognosis and limited effective treatment options. PURPOSE: To evaluate the safety and efficacy of irradiation stent placement (ISP) followed by transcatheter arterial chemoembolization (TACE) plus immune …

cn (code pays fourni par la source)

[A multicenter prospective study on early identification of refractory Mycoplasma pneumoniae pneumonia in children].

Dan Feng Xu, Angel Zhang, J S Zheng, Ming Ye et autres

In MPP patients with fever over 48 to <120 hours, a prediction probability π of RMPP can be calculated based on the peak body temperature and LDH level before the first visit, which can facilitate early identification of RMPP.

cn (code pays fourni par la source)

TACE Combined with Immunotherapy Plus Targeted Therapy After 125I Irradiation Stent Placement in HCC with Main Portal Vein Tumor Thrombosis (PATENCY II)

Jiakun Mei, Zhicheng Jin, Jiaping Zheng, Wei‐Fu Lv et autres

bd, cn (code pays fourni par la source)